Defunct Company
Total Trials
6
As Lead Sponsor
1
As Collaborator
5
Total Enrollment
1,440
NCT00558337
Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 30, 2007
Completion: Dec 31, 2008
NCT01743651
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
Phase: Phase 3
Role: Collaborator
Start: Nov 30, 2012
Completion: Apr 30, 2014
NCT01844232
One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity
Start: Apr 30, 2013
Completion: Jan 31, 2015
NCT02869425
To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS
Start: Jul 31, 2016
Completion: Jan 31, 2019
NCT03290131
A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS
Start: Jan 28, 2018
Completion: Jan 2, 2019
NCT03319732
A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS
Start: Apr 3, 2018
Completion: Jun 11, 2020